PPD's owners Hellman & Friedman and Carlyle to recapitalize company
Contract research organization Pharmaceutical Product Development's existing owners Hellman & Friedman and The Carlyle Group have agreed to recapitalize PPD. Also, Abu Dhabi Investment Authority and GIC, Singapore's sovereign wealth fund, will acquire minority ownership stakes in PPD. Both Hellman & Friedman and Carlyle will remain majority shareholders in PPD. The transaction puts PPD at a valuation of $9.05 billion. Goldman Sachs, J.P. Morgan Securities LLC, and Centerview Partners served as financial advisers to PPD.
26 April 2017•5 mins read
